← Back to Intel
Insider ActivityBBIO
Apuli Maricel, Chief Accounting Officer at BridgeBio Pharma, Inc., sold $143K of BBIO
Updated Jun 14, 2026
Apuli Maricel
Chief Accounting Officer
BridgeBio Pharma, Inc. ·
$BBIO
Transaction Details
| Insider | Apuli Maricel |
|---|---|
| Title | Chief Accounting Officer |
| Company | BridgeBio Pharma, Inc. |
| Ticker | BBIO |
| Transaction Type | Sale |
| Transaction Date | 2026-04-30 |
| Shares Traded | 2,000 |
| Price Per Share | $71.58 |
| Total Value | $143K |
| Filed Date | 2026-05-04 |
| Accession Number | 0001470831-26-000410 |
Ownership Context
| Shares Owned After Transaction | 134,115 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001470831-26-000410
Other Insider Trades — BBIO
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Kumar Neil | Chief Executive Officer, Director | sold | $305K | 2026-06-05 |
| Kumar Neil | Chief Executive Officer, Director | sold | $573K | 2026-06-05 |
| Kumar Neil | Chief Executive Officer, Director | sold | $304K | 2026-06-05 |
| Kumar Neil | Chief Executive Officer, Director | sold | $480K | 2026-06-05 |
| Kumar Neil | Chief Executive Officer, Director | sold | $480K | 2026-06-05 |
| Kumar Neil | Chief Executive Officer, Director | sold | $1.1M | 2026-06-04 |
| Kumar Neil | Chief Executive Officer, Director | sold | $95K | 2026-06-04 |
| Kumar Neil | Chief Executive Officer, Director | sold | $31K | 2026-06-04 |
| Kumar Neil | Chief Executive Officer, Director | sold | $145K | 2026-06-04 |
| Kumar Neil | Chief Executive Officer, Director | sold | $793K | 2026-05-21 |
Other Trades by Apuli Maricel
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | traded | $312K | 2026-05-16 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for BBIO — BridgeBio Pharma, Inc. →
Track BBIO insider activity in real time on The Wire →
Get alerts when Apuli Maricel files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:15 UTC